loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 202810 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Supernus Pharmaceuticals

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    PharmaCompass

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 SUPERNUS PHARMS (3)

    filter

    01 TABLET, EXTENDED RELEASE;ORAL (3)

    filter

    01 RX (3)

    filter

    01 OXTELLAR XR (3)

    filter

    01 Yes (3)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag U.S.A
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      OXCARBAZEPINE

      PDF Supplier PDF
      URL Supplier Web Content
      TABLET, EXTENDED R...
      600MG
      2012-10-19
      202810
      OXTELLAR XR
      RX
      Yes
      AB
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content
      Contact Supplier
        Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
        Post an Enquiry Post an Enquiry
        Flag U.S.A
        Virtual Booth Virtual Booth
        Digital Content Digital Content

        OXCARBAZEPINE

        PDF Supplier PDF
        URL Supplier Web Content
        TABLET, EXTENDED R...
        150MG
        2012-10-19
        202810
        OXTELLAR XR
        RX
        Yes
        AB
        ASK
        US
        PHARMACOMPASS
        Upload
        your Marketing & Sales content
        Contact Supplier
          Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
          Post an Enquiry Post an Enquiry
          Flag U.S.A
          Virtual Booth Virtual Booth
          Digital Content Digital Content

          OXCARBAZEPINE

          PDF Supplier PDF
          URL Supplier Web Content
          TABLET, EXTENDED R...
          300MG
          2012-10-19
          202810
          OXTELLAR XR
          RX
          Yes
          AB
          ASK
          US
          PHARMACOMPASS
          Upload
          your Marketing & Sales content

          Looking for FDA Orange Book APPLICATION 202810

          Looking for FDA Orange Book APPLICATION 202810 3

          19

          Supernus Pharmaceuticals, based in U.S.A, is a pharmaceutical company.

          One of their notable products is OXCARBAZEPINE, with a corresponding application number 202810.

          Regulatory Information RX

          With a dosage strength 600MG

          Dosage Form Route TABLET, EXTENDED RELEASE; ORAL

          Reference Listed Drug Yes

          Approved since 2012-10-19

          Therapeutic Equivalence (TE) Code AB

          18

          Supernus Pharmaceuticals, based in U.S.A, is a pharmaceutical company.

          One of their notable products is OXCARBAZEPINE, with a corresponding application number 202810.

          Regulatory Information RX

          With a dosage strength 150MG

          Dosage Form Route TABLET, EXTENDED RELEASE; ORAL

          Reference Listed Drug Yes

          Approved since 2012-10-19

          Therapeutic Equivalence (TE) Code AB

          17

          Supernus Pharmaceuticals, based in U.S.A, is a pharmaceutical company.

          One of their notable products is OXCARBAZEPINE, with a corresponding application number 202810.

          Regulatory Information RX

          With a dosage strength 300MG

          Dosage Form Route TABLET, EXTENDED RELEASE; ORAL

          Reference Listed Drug Yes

          Approved since 2012-10-19

          Therapeutic Equivalence (TE) Code AB

          Post Enquiry
          POST ENQUIRY